Aclaris Therapeutics (ACRS) Non-cash Items (2014 - 2026)

Aclaris Therapeutics' Non-cash Items history runs 13 years deep, the most recent figure standing at $14.7 million for Q1 2026.

• In Q1 2026, Non-cash Items rose 1878.57% year-over-year to $14.7 million; the TTM figure through Mar 2026 stood at $14.7 million (up 1878.57% YoY), while the FY2025 annual figure was $8.6 million, up 189.66% from the prior year.
• Non-cash Items was $14.7 million for Q1 2026 at Aclaris Therapeutics, up from $8.6 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $23.2 million in Q1 2022 to a low of $13000.0 in Q3 2024.
• Historically, Non-cash Items has averaged $9.0 million across 5 years, with a median of $8.6 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Non-cash Items plunged 99.91% in 2023, then surged 21100.0% in 2024.
• A 5-year view of Non-cash Items shows it stood at $15.3 million in 2022, then slumped by 99.91% to $14000.0 in 2023, then soared by 21100.0% to $3.0 million in 2024, then soared by 189.66% to $8.6 million in 2025, then soared by 70.77% to $14.7 million in 2026.
• The last three Non-cash Items figures came in at $14.7 million (Q1 2026), $8.6 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.